Evidence map›Paper›PMID 30568248›Full record

ArticleNature communications2018

Author Correction: Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells.

Sabine Klawitter, Nina V Fuchs, Kyle R Upton, Martin Muñoz-Lopez, Ruchi Shukla, Jichang Wang, Marta Garcia-Cañadas, Cesar Lopez-Ruiz, Daniel J Gerhardt, Attila Sebe and 17 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. LINE-1 Retrotransposition Assays in Embryonic Stem Cells.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 9 institutions in 5 countries.

Sabine KlawitterDivision of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
Nina V FuchsDivision of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
Kyle R UptonMater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland, 4102, Australia.
Martin Muñoz-LopezDepartment of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain.
Ruchi ShuklaMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK.
Jichang WangMax-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany.
Marta Garcia-CañadasDepartment of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain.
Cesar Lopez-RuizDepartment of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain.
Daniel J GerhardtMater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland, 4102, Australia.
Attila SebeDivision of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
Ivana GrabundzijaMax-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany.
Sylvia MerkertLeibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625, Hannover, Germany.
Patricia GerdesMater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland, 4102, Australia.
J Andres PulgarinDepartment of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain.
Anja BockDivision of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
Ulrike HeldDivision of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
Anett WitthuhnLeibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625, Hannover, Germany.
Alexandra HaaseLeibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625, Hannover, Germany.
Balázs SarkadiDepartment of Biophysics and Radiation Biology, Semmelweis University, H-1094, Budapest, Hungary.
Johannes LöwerDivision of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
Ernst J WolvetangAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, 4072, Australia.
Ulrich MartinLeibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625, Hannover, Germany.
Zoltán IvicsDivision of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
Zsuzsanna IzsvákMax-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany.
Jose L Garcia-PerezDepartment of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain. jlgp@genyo.es.
Geoffrey J FaulknerMater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland, 4102, Australia. faulknergj@gmail.com.
Gerald G SchumannDivision of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany. Gerald.Schumann@pei.de.
Paul Ehrlich Institut · DEPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESUniversity of Queensland · AUMax Delbrück Center · DELeibniz Association · DEMedizinische Hochschule Hannover · DEMater Research · AUMRC Institute of Genetics and Molecular Medicine · GBSemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This Article contains an error in the author affiliations. The correct affiliation for author Ruchi Shukla is 'MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK', and is not 'Mater Research Institute - University of Queensland, TRI Building, Woolloongabba QLD 4102, Australia'.

Identifiers

PMID30568248
PMCPMC6300592
OpenAlexW2903683273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.